ClassID:

109035

C12N15/1062 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Processes for the isolation, preparation or purification of DNA or RNA; Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently

Recent Application in this class:
#1
20260071237
2026-03-12

ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS

#2
20250333725
2025-10-30

BIOLOGICALLY SELECTED NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES

#3
20250263690
2025-08-21

PROTEIN LIBRARY DISPLAY SYSTEMS AND METHODS THEREOF

#4
20250197843
2025-06-19

INSTRUMENT AND METHODS INVOLVING HIGH-THROUGHPUT SCREENING AND DIRECTED EVOLUTION OF MOLECULAR FUNCTIONS

#5
20250179691
2025-06-05

MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO CARBOHYDRATE-BINDING MONOCLONAL ANTIBODY FAMILY PGT128

#6
20250179472
2025-06-05

NUCLEIC ACID-TAGGED COMPOSITIONS AND METHODS FOR MULTIPLEXED PROTEIN-PROTEIN INTERACTION PROFILING

#7
20250171929
2025-05-29

PLATFORM FOR DISCOVERY AND ANALYSIS OF THERAPEUTIC AGENTS

#8
20250144104
2025-05-08

DISCOVERY OF A NEW INHIBITOR FOR THE YTH DOMAIN-CONTAINING M6A RNA READERS

#9
20250034552
2025-01-30

COMPOSITIONS AND METHODS FOR ISOLATION OF RIBOSOME PROTECTED MESSENGER RNA (mRNA) FOOTPRINTS OR FRAGMENTS AND KITS THEREOF

#10
20240344241
2024-10-17

PROTEINACEOUS MOLECULES AND USES THEREFOR

#11
20240327822
2024-10-03

MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES

#12
20240287708
2024-08-29

GENERATING RECOMBINANT AFFINITY REAGENTS WITH ARRAYED TARGETS

#13
20240279642
2024-08-22

METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES

#14
20240263355
2024-08-08

mRNA display antibody library and methods

#15
20240229015
2024-07-11

tRNA, AMINOACYL tRNA, REAGENT FOR POLYPEPTIDE SYNTHESIS, INTRODUCTION METHOD OF UNNATURAL AMINO ACID, PRODUCTION METHOD OF POLYPEPTIDE, PRODUCTION METHOD OF NUCLEIC ACID DISPLAY LIBRARY, NUCLEIC ACID-POLYPEPTIDE CONJUGATE, AND SCREENING METHOD

#16
20240190945
2024-06-13

mRNA display antibody library and methods

#17
20240167020
2024-05-23

ANALYZING EXPRESSION OF PROTEIN-CODING VARIANTS IN CELLS

#18
20240150750
2024-05-09

ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF

#19
20240132875
2024-04-25

Single-Molecule Phenotype Analysis

#20
20240067953
2024-02-29

METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES

#21
20240016927
2024-01-18

MODULAR TARGETED THERAPEUTIC AGENTS AND METHODS OF MAKING SAME

#22
20240011019
2024-01-11

Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling

#23
20240003057
2024-01-04

PLATFORM FOR DISCOVERY AND ANALYSIS OF THERAPEUTIC AGENTS

#24
20230382964
2023-11-30

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#25
20230340046
2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#26
20230287069
2023-09-14

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#27
20230279066
2023-09-07

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#28
20230212555
2023-07-06

METHODS AND COMPOSITIONS FOR IDENTIFYING TRAITS USING A CELL-FREE SYSTEM

#29
20230203477
2023-06-29

NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES

#30
20230193284
2023-06-22

TRANSMEMBRANE SERINE PROTEASE 2 (TMPRSS2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#31
20230193245
2023-06-22

METHODS AND COMPOSITIONS FOR MAKING AND USING PEPTIDE ARRAYS

#32
20230192791
2023-06-22

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#33
20230183885
2023-06-15

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

#34
20230174602
2023-06-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#35
20230148369
2023-05-11

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#36
20230138328
2023-05-04

METHODS AND USE OF CHIMERIC PROTEINS

#37
20230125614
2023-04-27

IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING

#38
20230125179
2023-04-27

In immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#39
20230116279
2023-04-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#40
20230109584
2023-04-06

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#41
20230100686
2023-03-30

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#42
20230094553
2023-03-30

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#43
20230094286
2023-03-30

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#44
20230069218
2023-03-02

METHOD FOR PRODUCING PEPTIDE CONTAINING NON-NATURAL AMINO ACID

#45
20230051523
2023-02-16

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#46
20230046543
2023-02-16

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#47
20230043654
2023-02-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#48
20230042253
2023-02-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#49
20230040789
2023-02-09

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#50
20230035702
2023-02-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#51
20230021673
2023-01-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#52
20230002755
2023-01-05

METHOD FOR PRODUCING NON-RIBOSOMAL RNA-CONTAINING SAMPLE

#53
20230002461
2023-01-05

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#54
20220389068
2022-12-08

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#55
20220364045
2022-11-17

TRANSGENIC BACTERIA AND METHODS OF USING SAME

#56
20220363730
2022-11-17

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#57
20220363729
2022-11-17

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#58
20220348622
2022-11-03

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#59
20220348621
2022-11-03

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#60
20220325296
2022-10-13

ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS

#61
20220275535
2022-09-01

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

#62
20220267392
2022-08-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#63
20220267391
2022-08-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#64
20220260581
2022-08-18

PEPTIDE CONSTRUCTS AND ASSAY SYSTEMS

#65
20220257701
2022-08-18

Methods and compositions for identifying neoantigens for use in treating cancer

#66
20220251544
2022-08-11

Methods and compositions for identifying neoantigens for use in treating and preventing cancer

#67
20220235107
2022-07-28

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#68
20220213467
2022-07-07

ASSEMBLY OF PROTEIN COMPLEXES ON A CHIP

#69
20220169692
2022-06-02

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#70
20220169691
2022-06-02

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#71
20220162277
2022-05-26

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#72
20220153796
2022-05-19

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#73
20220143091
2022-05-12

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#74
20220135636
2022-05-05

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#75
20220127320
2022-04-28

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#76
20220112254
2022-04-14

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#77
20220090055
2022-03-24

Multivalent glycopeptides that tightly bind to carbohydrate-binding monoclonal antibody family PGT128

#78
20220073904
2022-03-10

DEVICES AND METHODS FOR DISPLAY OF ENCODED PEPTIDES, POLYPEPTIDES, AND PROTEINS ON DNA

#79
20220049244
2022-02-17

Single cell bar-coding for antibody discovery

#80
20220009983
2022-01-13

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#81
20210403902
2021-12-30

Methods of Selecting and Detecting Binding Peptides

#82
20210380973
2021-12-09

TCR libraries

#83
20210380970
2021-12-09

Generating recombinant affinity reagents with arrayed targets

#84
20210363211
2021-11-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#85
20210363210
2021-11-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#86
20210363209
2021-11-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#87
20210363208
2021-11-25

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#88
20210340204
2021-11-04

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#89
20210277083
2021-09-09

GM-CSF and IL-4 Conjugates, Compositions, and Methods Related Thereto

#90
20210261948
2021-08-26

mRNA display antibody library and methods

#91
20210246181
2021-08-12

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#92
20210238587
2021-08-05

MRNA display antibody library and methods

#93
20210238581
2021-08-05

METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES

#94
20210130808
2021-05-06

Antigen binding molecules and methods of use thereof

#95
20210079381
2021-03-18

High-speed in vitro screening method

#96
20210002340
2021-01-07

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#97
20200339662
2020-10-29

Fibronectin binding domains with reduced immunogenicity

#98
20200338126
2020-10-29

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#99
20200325193
2020-10-15

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#100
20200325192
2020-10-15

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#101
20200325191
2020-10-15

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#102
20200308573
2020-10-01

Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling

#103
20200308572
2020-10-01

Modification of D- and T-arms of tRNA enhancing D-amino acid and β-amino acid uptake

#104
20200299346
2020-09-24

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#105
20200283761
2020-09-10

Method for producing complex of RNA molecule and peptide, and utilization thereof

#106
20200199579
2020-06-25

Rapid display method in translational synthesis of peptide

#107
20200172897
2020-06-04

X-display complexes for protein screening methods

#108
20200157162
2020-05-21

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#109
20200140853
2020-05-07

Multivalent glycopeptides that tightly bind to target proteins

#110
20200123229
2020-04-23

Fibronectin binding domains with reduced immunogenicity

#111
20200102555
2020-04-02

Directed evolution of multivalent glycopeptides that tightly bind to target proteins

#112
20200095574
2020-03-26

AN ENGINEERED MULTI-COMPONENT SYSTEM FOR IDENTIFICATION AND CHARACTERISATION OF T-CELL RECEPTORS, T-CELL ANTIGENS AND THEIR FUNCTIONAL INTERACTION

#113
20200072850
2020-03-05

Mapping protein binding sites and conformational epitopes using cysteine labelling and surface display library

#114
20200048630
2020-02-13

Single cell bar-coding for antibody discovery

#115
20200048629
2020-02-13

Devices and methods for display of encoded peptides, PolyPeptides, and proteins on DNA

#116
20200040050
2020-02-06

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#117
20190382755
2019-12-19

METHODS OF SCREENING, SELECTING, AND IDENTIFYING CYTOTOXIC RECOMBINANT POLYPEPTIDES BASED ON AN INTERIM DIMINUTION OF RIBOTOXICITY

#118
20190284250
2019-09-19

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#119
20190284249
2019-09-19

BETA-CATENIN BARCODED PEPTIDES

#120
20190264198
2019-08-29

Single cell bar-coding for antibody discovery

#121
20190264195
2019-08-29

mRNA display antibody library and methods

#122
20190248857
2019-08-15

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#123
20190241631
2019-08-08

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#124
20190241630
2019-08-08

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#125
20190233813
2019-08-01

Method of discovering specific functional antibodies

#126
20190233489
2019-08-01

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#127
20190233488
2019-08-01

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#128
20190231870
2019-08-01

Modular targeted therapeutic agents and methods of making same

#129
20190202894
2019-07-04

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#130
20190153432
2019-05-23

MRNA display antibody library and methods

#131
20190112730
2019-04-18

Platform for discovery and analysis of therapeutic agents

#132
20190100566
2019-04-04

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#133
20190093101
2019-03-28

Antigen binding molecules and methods of use thereof

#134
20190092823
2019-03-28

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS

#135
20190062728
2019-02-28

Generating recombinant affinity reagents with arrayed targets

#136
20190048333
2019-02-14

TCR libraries

#137
20190016772
2019-01-17

GM-CSF and IL-4 conjugates, compositions, and methods related thereto

#138
20190010198
2019-01-10

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers

#139
20180334760
2018-11-22

GENERATION OF LIBRARY OF SOLUBLE RANDOM POLYPEPTIDES LINKED TO mRNA

#140
20180328936
2018-11-15

Peptide constructs and assay systems

#141
20180312539
2018-11-01

METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME

#142
20180245141
2018-08-30

Encoded self-assembling chemical libraries (ESACHEL)

#143
20180245070
2018-08-30

DNA DISPLAY AND METHODS THEREOF

#144
20180216102
2018-08-02

Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting

#145
20180201923
2018-07-19

Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling

#146
20180162926
2018-06-14

Libraries of modified fibronectin type III tenth domain-containing polypeptides

#147
20180127743
2018-05-10

Methods of single-cell barcoding and sequencing

#148
20180112210
2018-04-26

BROAD-SPECTRUM SEROLOGICAL DIAGNOSTICS AND USES THEREOF

#149
20180105808
2018-04-19

METHODS AND SYSTEMS FOR BARCODING NUCLEIC ACID MOLECULES FROM INDIVIDUAL CELLS OR CELL POPULATIONS

#150
20180094256
2018-04-05

Protein screening methods

#151
20180017573
2018-01-18

POLYNUCLEOTIDE CONSTRUCT CAPABLE OF DISPLAYING FAB IN A CELL-FREE TRANSLATION SYSTEM, AND METHOD FOR MANUFACTURING AND SCREENING FAB USING SAME

#152
20170321220
2017-11-09

Presentation of bioactive proteins

#153
20170247686
2017-08-31

Single-molecule phenotype analysis

#154
20170247416
2017-08-31

Peptide with safer secondary structure, peptide library, and production methods for same

#155
20170198282
2017-07-13

Protein and peptide libraries

#156
20170190761
2017-07-06

Methods of treating cancer by administering IGF-IR binding molecules

#157
20170175108
2017-06-22

BARCODED PEPTIDES

#158
20170159046
2017-06-08

Method for producing peptides having azole-derived skeleton

#159
20170137494
2017-05-18

Fibronectin binding domains with reduced immunogenicity

#160
20170088586
2017-03-30

Methods and compositions for controlling gene expression and treating cancer

#161
20170081658
2017-03-23

Rapid Affinity Measurement of Peptide Ligands and Reagents Therefor

#162
20170071912
2017-03-16

Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases

#163
20170037109
2017-02-09

Fibronectin binding domains with reduced immunogenicity

#164
20160355803
2016-12-08

Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity

#165
20160354479
2016-12-08

FUNCTIONALIZED POLYPEPTIDES

#166
20160312212
2016-10-27

COW ANTIBODY SCAFFOLD POLYPEPTIDE METHOD AND COMPOSITION

#167
20160304858
2016-10-20

Directed evolution of multivalent glycopeptides that tightly bind to target proteins

#168
20160304628
2016-10-20

Multivalent glycopeptides that tightly bind to target proteins

#169
20160289668
2016-10-06

Production method for charged non-protein amino acid-containing peptide

#170
20160272964
2016-09-22

Method for producing peptide library, peptide library, and screening method

#171
20160251400
2016-09-01

HIGH AFFINITY ADAPTOR MOLECULES FOR REDIRECTING ANTIBODY SPECIFITY

#172
20160237424
2016-08-18

High throughput generation and affinity maturation of humanized antibody

#173
20160222377
2016-08-04

METHOD FOR GENERATING ULTRA HIGH AFFINITY PEPTIDE LIGANDS

#174
20160168563
2016-06-16

Efficient method for displaying protein multimer

#175
20160122752
2016-05-05

Methods for obtaining information from single cells within populations using DNA origami nanostructures without the need for single cell sorting

#176
20160122751
2016-05-05

Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling

#177
20160097050
2016-04-07

Devices and methods for display of encoded peptides, polypeptides, and proteins on DNA

#178
20160076022
2016-03-17

Nucleic acid linker

#179
20160068835
2016-03-10

FLEXIBLE DISPLAY METHOD

#180
20160040158
2016-02-11

Protein screening methods

#181
20160032282
2016-02-04

Single cell bar-coding for antibody discovery

#182
20150353924
2015-12-10

Generation of library of soluble random polypeptides linked to mRNA

#183
20150218227
2015-08-06

PEPTIDES FOR THE BINDING OF NUCLEOTIDE TARGETS

#184
20150191571
2015-07-09

Polyamide compound and pharmaceutical composition for treating mitochondrial genetic disease

#185
20150166988
2015-06-18

Methods and compositions

#186
20150051149
2015-02-19

Fibronectin binding domains with reduced immunogenicity

#187
20150031564
2015-01-29

Ligand having three finger structure and a method for detecting a molecule by using thereof

#188
20140357500
2014-12-04

Single cell bar-coding for antibody discovery

#189
20140296111
2014-10-02

Protein-immobilizing solid phase, polynucleotide-immobilizing solid phase, and nucleic acid recovery method

#190
20140243209
2014-08-28

Method for detecting protein that interacts with target substance

#191
20140234898
2014-08-21

Protein and peptide libraries

#192
20140187757
2014-07-03

Connector compound peptide phage display

#193
20140178386
2014-06-26

Functionalized polypeptides

#194
20140113830
2014-04-24

Azoline compound and azole compound library and method for producing same

#195
20140051589
2014-02-20

Peptide constructs and assay systems

#196
20140018257
2014-01-16

Peptide library production method, peptide library, and screening method

#197
20130316910
2013-11-28

Peptide with safer secondary structure, peptide library, and production methods for same

#198
20130288930
2013-10-31

Efficient method for displaying protein multimer

#199
20130288908
2013-10-31

Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same

#200
20130245238
2013-09-19

Fibronectin binding domains with reduced immunogenicity

#201
20130230884
2013-09-05

Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation

#202
20130196871
2013-08-01

Fibronectin binding domains with reduced immunogenicity

#203
20130196331
2013-08-01

Constitution of tool for analyzing biomolecular interaction and analysis method using same

#204
20130190189
2013-07-25

In vitro sorting method

#205
20130183312
2013-07-18

Modular targeted therapeutic agents and methods of making same

#206
20130178394
2013-07-11

Method for constructing libraries of non-standard peptide compounds comprising N-methyl amino acids and other special (non-standard) amino acids and method for searching and identifying active species

#207
20120283184
2012-11-08

Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides

#208
20120271033
2012-10-25

High affinity adaptor molecules for redirecting antibody specifity

#209
20120270748
2012-10-25

PEPTIDE DISPLAY ARRAYS

#210
20120258871
2012-10-11

PEPTIDE CONSTRUCTS AND ASSAY SYSTEMS

#211
20120208720
2012-08-16

RAPID DISPLAY METHOD IN TRANSLATIONAL SYNTHESIS OF PEPTIDE

#212
20110319278
2011-12-29

Encoded self-assembling chemical libraries (ESACHEL)

#213
20110212119
2011-09-01

METHODS FOR MAKING HIV VACCINES AND RELATED COMPOSITIONS

#214
20110200594
2011-08-18

Functionalized polypeptides

#215
20110183863
2011-07-28

Protein screening methods

#216
20100317547
2010-12-16

Methods and compositions

#217
20100310549
2010-12-09

Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors

#218
20100184611
2010-07-22

Encoded self-assembling chemical libraries (ESACHEL)

#219
20100121033
2010-05-13

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#220
20100113302
2010-05-06

Generation of library of soluble random polypeptides linked to mRNA

#221
20090325236
2009-12-31

Optical sorting method

#222
20090264298
2009-10-22

Methods for enriching subpopulations

#223
20090203530
2009-08-13

Polymer evolution via templated synthesis

#224
20090053700
2009-02-26

Optical sorting method

#225
20080312103
2008-12-18

Linker for constructing mRNA-puromycin-protein conjugate

#226
20080058217
2008-03-06

Selection of proteins using RNA-protein fusions

#227
20080051299
2008-02-28

DNA-protein fusions and uses thereof

#228
20070298430
2007-12-27

Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein

#229
20070259374
2007-11-08

In vitro sorting method

#230
20070160533
2007-07-12

Pharmacokinetic modulation and compositions for modified FN3 polypeptides

#231
20070148126
2007-06-28

Inhibitors of type 2 vascular endothelial growth factor receptors

#232
20070077579
2007-04-05

In vitro sorting method

#233
20070015181
2007-01-18

System and methods for nucleic acid and polypeptide selection

#234
20060246549
2006-11-02

Peptide acceptor ligation methods

#235
20060246515
2006-11-02

High throughput generation and affinity maturation of humanized antibody

#236
20060183200
2006-08-17

Methods and means relating to protein variants

#237
20060154246
2006-07-13

Encoded self-assembling chemical libraries (esachel)

#238
20060040314
2006-02-23

Methods for screening polypeptides

#239
20050260653
2005-11-24

Nucleic-acid programmable protein arrays

#240
20050191626
2005-09-01

Method for forming a stable complex comprising a transcription product and translation product of a dna encoding a desired polypeptide, a nucleic acid construct used for the method, a complex formed by the method, and screening of a functional protein and mrna or dna encoding the protein using the method

#241
20050170403
2005-08-04

Combinatorial enzymatic complexes

#242
20050164239
2005-07-28

Optical sorting method

#243
20050118687
2005-06-02

Methods of synthesizing polynucleotide via reverse translation from protein and oligonucleotide used in this method

#244
20050089913
2005-04-28

Compositions and methods for the identification and selection of nucleic acids and polypeptides

#245
20050069920
2005-03-31

In Vitro sorting method

#246
20050042648
2005-02-24

In vitro sorting method

#247
20050037392
2005-02-17

Optical sorting method

#248
17465597
2022-06-07

Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers